BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 15642151)

  • 1. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models.
    Lubberts E; Koenders MI; van den Berg WB
    Arthritis Res Ther; 2005; 7(1):29-37. PubMed ID: 15642151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance.
    Lubberts E; van den Bersselaar L; Oppers-Walgreen B; Schwarzenberger P; Coenen-de Roo CJ; Kolls JK; Joosten LA; van den Berg WB
    J Immunol; 2003 Mar; 170(5):2655-62. PubMed ID: 12594294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-18: a therapeutic target in rheumatoid arthritis?
    McInnes IB; Liew FY; Gracie JA
    Arthritis Res Ther; 2005; 7(1):38-41. PubMed ID: 15642152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKL.
    Hui W; Cawston TE; Richards CD; Rowan AD
    Arthritis Res Ther; 2005; 7(1):R57-64. PubMed ID: 15642143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
    van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
    Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1.
    Koenders MI; Lubberts E; Oppers-Walgreen B; van den Bersselaar L; Helsen MM; Di Padova FE; Boots AM; Gram H; Joosten LA; van den Berg WB
    Am J Pathol; 2005 Jul; 167(1):141-9. PubMed ID: 15972960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proinflammatory cytokine interleukin-17 and its role in pathogenesis of rheumatoid arthritis].
    Leonaviciene L; Bradūnaite R; Astrauskas V
    Medicina (Kaunas); 2004; 40(5):419-22. PubMed ID: 15170409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone destruction in arthritis.
    Gravallese EM
    Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii84-6. PubMed ID: 12379632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.
    Romas E; Gillespie MT; Martin TJ
    Bone; 2002 Feb; 30(2):340-6. PubMed ID: 11856640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
    Dai SM; Nishioka K; Yudoh K
    Ann Rheum Dis; 2004 Nov; 63(11):1379-86. PubMed ID: 15479886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-allergic compound tranilast attenuates inflammation and inhibits bone destruction in collagen-induced arthritis in mice.
    Shiota N; Kovanen PT; Eklund KK; Shibata N; Shimoura K; Niibayashi T; Shimbori C; Okunishi H
    Br J Pharmacol; 2010 Feb; 159(3):626-35. PubMed ID: 20067475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synovial IL-21/TNF-producing CD4
    Lebre MC; Vieira PL; Tang MW; Aarrass S; Helder B; Newsom-Davis T; Tak PP; Screaton GR
    J Leukoc Biol; 2017 Mar; 101(3):775-783. PubMed ID: 27733582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological characterization of receptor activator of NFkappaB ligand (RANKL) and IL-1beta expression in rodent collagen-induced arthritis.
    Weiss RJ; Erlandsson Harris H; Wick MC; Wretenberg P; Stark A; Palmblad K
    Scand J Immunol; 2005 Jul; 62(1):55-62. PubMed ID: 16092922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis.
    Kotake S; Udagawa N; Takahashi N; Matsuzaki K; Itoh K; Ishiyama S; Saito S; Inoue K; Kamatani N; Gillespie MT; Martin TJ; Suda T
    J Clin Invest; 1999 May; 103(9):1345-52. PubMed ID: 10225978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Involvement of osteoclasts in cartilage and bone destruction in rheumatoid arthritis].
    Hikita A; Tanaka S
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():84-6. PubMed ID: 15799323
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathophysiological roles for IL-18 in inflammatory arthritis.
    Matsui K; Tsutsui H; Nakanishi K
    Expert Opin Ther Targets; 2003 Dec; 7(6):701-24. PubMed ID: 14640907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-rheumatoid arthritis effects of iridoid glucosides from Lamiophlomis rotata (Benth.) kudo on adjuvant-induced arthritis in rats by OPG/RANKL/NF-κB signaling pathways.
    Zhao X; Jiang S; Dong Q; Dang J; Liu Z; Han H; Tao Y; Yue H
    J Ethnopharmacol; 2021 Feb; 266():113402. PubMed ID: 32980481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.